Trial Details
An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis
NCT00355901
TERMINATED
DESCRIPTION
To assess the effects of visilizumab on the safety of subsequent salvage therapies in subjects who experienced disease progression in a previous visilizumab study and subsequently received salvage therapy.
CONDITIONS
Ulcerative Colitis
ELIGIBILITY CRITERIA
- Inclusion Criteria
- :
- Previous participation in a visilizumab study of IVSR-UC.
- Disease progression while enrolled in a previous visilizumab study, and subsequent treatment with salvage therapy.
- Exclusion Criteria
- :
- Unable to understand the purpose and risks of the study, or unwilling or unable to provide a signed and dated informed consent.
- For U.S. sites, unwilling or unable to provide authorization to use protected health information.
